Elvanse 20mg

    ELVANSE 20 MG HARD CAPSULES

Elvanse is a treatment for ‘attention deficit hyperactivity disorder’ (ADHD). It is used: in children and young people between the ages of 6 and 18 who have previously taken a methylphenidate

Therapeutic indications

Elvanse is indicated as part of a comprehensive treatment programme for attention deficit/hyperac­tivity disorder (ADHD) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate.

Treatment must be under the supervision of a specialist in childhood and/or adolescent behavioural disorders. Diagnosis should be made according to DSM criteria or the guidelines in ICD and should be based on a complete history and evaluation of the patient. Diagnosis cannot be made solely on the presence of one or more symptom.

The specific aetiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use of medical and specialised psychological, educational, and social resources.

Elvanse: What you need to know – Child & Adolescent ADHD

Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you or your child

Elvanse is used in the treatment of ADHD (Attention Deficit Hyperactivity Disorder, ie attention deficit hyperactivity disorder). It is used in children and adolescents between 6 and 18

Elvanse (lisdexamfetamine) works by improving activity in the parts of the brain responsible for self-control and attention.

It helps to focus attention, improve concentration, and reduce impulsive behavior. Elvanse is a long-acting medicine that gradually works over a 13-hour time period.